Publications

Bibliography:

 Original Manuscripts ( Peer reviewed Journal Publications) :

1. Chaudhary Kunal, Smith RJ, Himelright IM and Baddour LM (1994) Purpura in Disseminated Strongyloidiasis. American J Med Sciences, 308:186-191.
2. Chaudhary Kunal, Faidas Anna and Baddour LM(1995) Candida pericarditis: An unusual complication following hiatal hernia repair. Inf Dis Clin Practice, Vol5:339-342.
3. Ashraf Muhammad, Chaudhary Kunal, Nelson J and Thompson WG (1996) Massive overdose with sustained release verapamil: A case report and review of literature. American J Med Sciences 310:258-63.
4. Chaudhary Kunal, Wall Barry M and Rasberry RD (2001) Livedo Reticularis: An underdiagnosed clue in patients with renal failure secondary to cholesterol embolization. American J Med Sciences, 321(5):348-351.
5. Whaley-Connell A, Pavey B, Chaudhary Kunal, Saab G, and Sowers J(2007) Renin –angiotensin-aldosterone system intervention in cardio metabolic syndrome and cardio-renal protection. Therapeutic Advances in CVD. Oct 2007 (1)27-35.
6. Chaudhary Kunal and Khanna Ramesh (2008) Renal Replacement Therapy in ESRD patients with chronic liver disease and ascites: Role of Peritoneal dialysis. Perit Dial Int.  28(2): 113-118.
7. Chaudhary Kunal, Shin Ji Young, Saab Georges, Luger Alan M. (2008):  Successful treatment of Henoch-Schonlein Purpura nephritis with plasma –exchange in an adult male:  A case report and review of literature. NDT plus 1(5) 303-306.
8. Young CN, Fisher  JP, Gallagher KM, Whaley-Connell Adam, Chaudhary Kunal, Victor RG, Thomas GD, Fadel P.(2009) Inhibition of Nitric oxide  synthase  increases sympathetic nerve activity in healthy humans. J Physiology, 587(20):4977-86
9. Chaudhary Kunal, Nistala R, Whaley-Connell A (2009): Dual RAAS Blockade in the ONTARGET Study: Clinically Relevant Risk for the Kidney.  Curr Hypertens Rep. 2009; 11(5):375-81.
10. Gupta Diptesh, Chaudhary Kunal, and Nistala Ravi (2010) Renal artery stenosis: What’s the fuss about? Rev recent clin trials 5(1): 28-34
11. Chaudhary Kunal and Khanna Ramesh (2010):  The Biocompatible Peritoneal Dialysis solutions: Do we have one? Clin J Am Soc Nephrol. 5(4): 723-32
12. Chaudhary Kunal,  Phadke Gautam, Nistala Ravi, Weidmeyer Charles E, McFarlane Samy I, Whaley-Connell A.  (2010):  The Emerging Role of Biomarkers in Diabetic and Hypertensive Chronic Kidney Disease. Current Diabetes Reports Vol 10:(1) 37-42.
13. Chaudhary Kunal, Haddadin Shadi, Nistala R, Papageorgio C. (2010) Intraperitoneal drug therapy: An advantage.  Current Clinical Pharmacology 5(2); 82-88
14. Chaudhary Kunal, Nistala R, Whaley-Connell A. (2010). Is there a future for renin inhibitors?  Expert Opinion On Investigational Drugs. 19(5): 653-61
15. Young Colin, Deo Shekhar, Chaudhary Kunal , Thyfault John P, and Fadel Paul J.(2010) Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans. J Physiology, Sep 15;588(Pt 18):3593-603.
16. Chaudhary Kunal,  Buddideni JP, Nistala R and Whaley-Connell A(2011). Management of Resistant  Hypertension in the high-risk Metabolic Syndrome population  Current Diabetes Reports Vol 11 (1): 41-46,
17. Chaudhary Kunal, Sangha H, and Khanna Ramesh (2011) Peritoneal Dialysis First: Rationale., Clin J Am Soc Nephrol Vol 6(2): 447-56.
18. Whaley-Connell A, Nistala R, Chaudhary Kunal (2011). The importance of early identification of Chronic Kidney disease Mo Medicine 108(1): 25-28
19. Chaudhary Kunal, Botdorf J, Whaley-Connell A. (2011):  Renovascular Hypertension: Pathogenesis and Treatment.  Mo Medicine 108(1): 37-41
20. Buddineni JP, Chaudhary Kunal, Whaley-Connell A (2011).  The emerging role of biomarkers in the diabetic population  Therapy 8(2): 121-127
21. Dalal Pranav, Sangha H, Chaudhary Kunal. (2011) In peritoneal dialysis is there sufficient evidence to make “PD first” therapy? Int J Nephrol Vol. 2011, Article ID 239515,  doi:10.4061/2011/239515
22. Botdorf Joshua, Chaudhary Kunal and Whaley-Connell A (2011) Management of Hypertension in chronic kidney disease population Cardiorenal Med; 1(3):183-192.
23. Chaudhary Kunal. (2011) What is the best chronic dialysis modality for ESRD patients with end stage liver disease?  Seminars in Dialysis 24(4): 414-15.
24.  Chaudhary Kunal. (2011) Peritoneal Dialysis drop out: causes and prevention strategies. Int J Nephrol Vol. 2011, Article ID 43608. doi:10.4061/2011/434608
25. Whaley-Connell Adam, Chaudhary Kunal,  Misra Madhukar, Khanna Ramesh (2011) A Case for Early Screening for Diabetic Kidney Disease Cardiorenal Med ;1(4):235-242
26. Lishmanov A, Dorairajan S, Pak Youngju, Chaudhary Kunal, Chockalingam A(2012) . Serum intact parathormone as a cardiovascular risk factor for patients with moderate CKD. Int Journal Urol Nephrol  ;44(2):541-7.
27. Yerram Preethi, Karuparthi PR, Chaudhary Kunal.(2012) Pathogenesis and management of renovascular disease and ischemic nephropathy Minerva Urol e Nefrol 64(1): 63-72.
28. Ramanath Vinayak, Nistala Ravi, Chaudhary Kunal.(2012) Update on the role of Rituximab in kidney diseases and transplant. Expert Opin Biol Ther.  12(2):223-33.
    
29. Ramanath Vinayak, Diptesh Gupta, Juhi Jain, Chaudhary Kunal and Nistala Ravi (2012).  Anemia and chronic kidney disease: making sense of recent trials. Rev Recent Clin Trials. 2012 Aug 1;7(3):187-96 
30. Bichu Prasad and Chaudhary Kunal. (2012) Non-Infectious Complications of Immunosuppressant Medications in Renal Transplant Patients Current Clin Pharmacology, 7(4): 254-62.  .
31. Chaudhary Kunal.  Current perspective on peritoneal dialysis. (2012) (Editorial). Journal of Nephrology and Therapeutics. 2:e107. doi:10.4172/2161-0959.1000e107
32. Ariyamuthu V, Balla Sudarshan and Chaudhary Kunal (2012).  Ischemic Heart disease in patients undergoing dialysis: Hospital Practice 2012 Oct;40(4):33-9. doi: 10.3810/hp. 2012.10.1001.
33. Chaudhary Kunal, Malhotra Kunal, Sowers James, and Aroor A.  (2013)  Uric acid: A Key ingredient in the recipe of cardiorenal metabolic syndrome Cardiorenal Med 2013, 3; 208-220
34. Lishmanov A, Dorairajan S, Pak Y, Chaudhary Kunal, Chockalingam A (2013) Treatment of 25 OH Vitamin D in CKD stage 3 and 4 patients reduces the risk for cardiovascular events. Am J  Ther.  20(5): 480-486 .
35. Yerram Preethi and Chaudhary Kunal.  Calcific uremic arteriolopathy in end stage renal disease patients: pathophysiology and management” (2014) The Ochsner Journal: Vol. 14, No. 3, pp. 380-385
36. Chaudhary Kunal  , Harold Moore,  Ashish Tandon, Suneel Gupta, Ramesh Khanna , and Rajiv R. Mohan.  Nanotechnology and Adeno-associated virus based decorin gene therapy ameliorates  Peritoneal Fibrosis . (2014)   Am J Physiol- Renal Physiol 307 ( 7)F777-782. DOI: 10.1152/ajprenal.00653.2013
37. Rao Akhilesh, Pandya Vishwam, , Chaudhary Kunal.   Lipid abnormalities  in kidney   disease and management strategies . (2014) World Journal of Nephrology  [in press]
38. Aziz Fahad, Chaudhary Kunal.  The triad of OSA, HTN and CKD . (2014) Postgraduate medicine [ in preparation]

Book Chapters:

1.  Hudson J and Chaudhary Kunal. Chronic Kidney Disease (2005) "DePiro/Pharmacotherapy; A Pathophysiologic Approach” 6th ed. Chapter 44, Pages 421-450. ISBN- 007-141613-7
2.  Buddineni J P, Chaudhary Kunal and Whaley-Connell A.(2012) “Predictors of Kidney disease development in diabetic hypertensive patients”. Diabetes and Hypertension. Humana Press, SpringerEditors: Samy McFarlane and George Bakris. Chapter 9, Pages 107-119, ISBN: 978-1-60327-356-5
3. Chaudhary Kunal, Buddineni J P, Botdorf Joshua,and Whaley-Connell A (2012) “Hypertension and chronic kidney disease” “Diabetes and Hypertension”, Humana Press, Springer. Editors: Samy McFarlane and George Bakris.Chapter 4, Pages 35-50, ISBN: 978-1-60327-356-5
4. Buddineni J P, Chaudhary Kunal, Sowers James R and Whaley-Connell A  (2014) “Cardiovascular disease in chronic kidney disease”.  Studies in Diabetes. Humana press, Springer. Editors: Irina Obrosova, Martin Stevens and Mark Yorek Chapter 4,  pages 49-61. ISBN: 978-1-4899-8034-2
5. Regunath Hariharan, Ariyamuthu Venkatesh, and Chaudhary Kunal.( 2014)  “Pathogenesis and management  of dialysis access infections ”.  Current trends in diagnosis, prognosis and treatment of surgical infections. Elsevier, Editors: Kateryna Kon and Mahendra Rai.  Chapter 8, 135-52 ISBN: 978-0-12-411629-0

Published Abstracts:

1. Muthuswamy J, Chaudhary Kunal, Thompson WG, Stevens S and Zemel MB(1995) Effects of Alpha-Tocopherol on the capacity of isolated LDL to stimulate intracellular ([Ca2+]i) response in vascular smooth muscle cells. Am J Clin Nutr 61(4):898
2. Hudson Joanna, Beireie Ingrid, Acchiardo Sergio and Chaudhary Kunal (1999) evaluation of medication use and drug related problems in an outpatient dialysis center. Pharmacotherapy, 20(3);366
3. Chaudhary Kunal, Gaber AO,  Egidi MF (2000) Conversion from Tacrolimus to Rapamycin in patients with Kidney and combined Kidney-Pancreas Transplant; a preliminary experience. J Am Soc Nephrol 2000(11):683A
4. Chaudhary Kunal, Sile Saba, Gaber L, Bastnagel WR. (2001) Cytomegalovirus associated collapsing glomerulonephritis in a non-immunocompromised patient with no risk factors. Am J Kidney Dis 2001 7(4):19A
5. Acchiardo SR, Green Christie and Chaudhary Kunal (2002) C-Reactive protein levels in hemodialysis patients with different vascular accesses.  J Am Soc Nephrology 2002 (13):409A
6. Chaudhary Kunal, Nayak KS (2003) Tuberculous osteomyelitis of clavicle and maxilla as occult infection in two renal transplant patients. Nephrol Dial Transpl 2003;18(S4):802
7. Chaudhary Kunal (2003) Lithium Toxicity: Dialysis vs Conservative Treatment. J Am Soc Nephrology 2003(14): 799A
8. Green Christie, Wall Barry, Chaudhary Kunal et al (2003) Acute phase reactants and mortality outcomes evaluated by type of vascular access in hemodialysis patients. J Am Soc Nephrology 2003(14): 509A
9. Whaley-Connell A, Sangha, Harbaksh, Chaudhary, Kunal and Saab Georges (2007)  Albuminuria and age as predictors of  erythropoietin response in chronic kidney disease . Am J Kidney Dis 49(4) B83.
10. Shin Ji Young, Singh Mandeep, Chaudhary Kunal (2008): Successful treatment of  Henoch-Schonlein Purpura nephritis with plasma –exchange  in an adult male.   Am J Kidney Dis 50(4) 88A.
11. Gupta Diptesh, Ji Young Shin, Chaudhary Kunal and Georges Saab (2009). Vitamin D levels are positively correlated with hemoglobin levels in diabetic patients with chronic kidney disease. J Am Soc Nephrology 2009(20) : 645A
12. Heismann L, Muppalla S, Phadke G, Saab G, Chaudhary Kunal.(2010) Chronic Kidney Disease negatively impacts survival in patients having carotid endarterectomy surgery. J Am Soc Nephrology 2010 (21): 414A
13. Dorairajan S, Lishmanov A, Pak J, Chaudhary Kunal, Chockalingam A.(2010)  High iPTH values are a risk factor for cardiovascular disease in moderate CKD. J Am Soc Nephrology 2010(21): 650A
14. Gautam M. Phadke, Amandeep Gill, Diptesh Gupta, Chaudhary Kunal, Misra Madhukar. (2010)  Infected Titanium Adapter: A Common Cause of Relapsing Peritonitis. J Am Soc Nephrology 2010 (21): 914A
15. Lishmanov A, Dorairajan S, Pak Youngju,  Chaudhary Kunal, Chockalingam A (2011) “Treatment of 25-OH Vitamin D deficiency in chronic kidney disease stage 3 and 4 patients reduces the risk for cardiovascular events”  Am J Kidney Dis  57(4) B59
16. Chaudhary Kunal,  Ashish Tandon, Harold Moore, Ramesh Khanna and Rajiv Mohan (2012) “Decorin gene therapy via hybrid nanoparticles and adeno-associated virus  leads to prevention of peritoneal fibrosis in a rat model of peritonitis”  Perit Dial Int  2012 (32) Supp 1 : S5

Presentations:

1. “Purpura as a presentation of Disseminated  Strongyloidiasis”: Annual joint meeting of the Tennessee   Chapter of the American College of Physicians and the  Tennessee Society of Internal Medicine, Gatlinburg, TN,   Oct 21-23, 1993 [Poster]
2. “Thyrotoxicosis Periodic Paralysis- A case of acquired flaccid paralysis in a Caucasian male”: Annual joint meeting of the Tennessee Chapter of the American College of Physicians and the Tennessee Society of Internal Medicine, Chattanooga TN, Nov 6-8, 1994[Poster]
3. “Sweet Syndrome-Recognize this diagnosis so the patient does not sour”: Annual joint meeting of the Tennessee Chapter of the American College of Physicians and the Tennessee Society of Internal Medicine, Chattanooga, TN,   Nov 6-8, 1994. [Poster]
4. “Effects of Oral alpha-tocopherol on the capacity of isolated LDL to stimulate  intracellular Calcium ([Ca2+]I) in vascular smooth muscle cells(VSMC’s)”. Annual meeting of the American Society of Clinical Nutrition, San Diego, CA, May 2-4, 1995.[Poster]
5. “Evaluation of medication use and drug related problems in an outpatient dialysis center: opportunity for pharmacist intervention”. Annual meeting of American College of Clinical Pharmacy, Monterey, CA, April 6-8, 2000. [Poster]
6. “Conversion from Tacrolimus to Rapamycin in patients with kidney or combined kidney-pancreas transplant: a preliminary experience” Annual meeting of American Society of Nephrology, Toronto, Canada, Oct 12-16, 2000 [Poster]
7. “Cytomegalovirus associated Collapsing Glomerulonephritis in a non-immunocompromised patient with no risk factors” Annual meeting of the National Kidney Foundation, Orlando, FL, April 17-21, 2001. [Poster]
8. “Cystic diseases of the kidneys” Grand Rounds , University of Tennessee Health Sciences Center, Memphis, TN, May 2001.
9.  “CRP levels in Hemodialysis patients with different vascular access” Annual meeting of American Society of Nephrology, Philadelphia, PA, Oct 30-Nov3, 2002 [Poster]
10. “Tuberculous Osteomyelitis of Clavicle and Maxilla in two renal Transplant recipients”. Annual meeting of the World Congress of Nephrology and European Dialysis and Transplant  Association, Berlin, Germany, June 8-11, 2003 [Poster 
11. "Acute phase reactants and mortality outcomes evaluated by type of vascular access" Annual meeting of American Society of Nephrology, San Diego, CA, November 14-17,2003[Poster]
12. “Cardiovascular disease in End Stage Renal disease” Le High Valley Hospital, Allentown, PA. May 12, 2004 [Grand Rounds]
13. “Acute Renal Failure: pathogenesis and management” University of Missouri Health Center, Columbia, MO. June, 2006 [Grand Rounds]
14. “Renal replacement therapy in ESRD patients with  Cirrhosis and Ascites” Annual Dialysis conference,  Denver , CO, March 1-4, 2007[Invited Lecture]
15. "Albuminuria and Age as predictors of Erythropoietin response in Chronic kidney  disease", Annual meeting of the National Kidney Foundation, Orlando, FL, April 10-14, 2007 [Poster]
16. "Successful treatment of Henoch-Schonlein Purpura nephritis with plasma – exchange in an adult male". Annual meeting of the National Kidney Foundation, Dallas, TX, April 1-4, 2008 [Poster]
17. “Cardiovascular disease in chronic kidney disease” University of Missouri Health Center, Columbia, MO. May , 2008 [Grand Rounds]
18. “Successful treatment of- PR3-ANCA-associated Glomerulonephritis using     Mycophenolate and plasma exchange.” Annual  meeting of the Missouri Chapter of the American College of Physicians; Lake of The Ozarks, MO. September 11-13,2008 [Poster]
19. “Update on Sevelamer hydrochloride” Annual Dialysis Conference, March 7-10, 2009, Houston, TX [Invited lecture].
20. “Renal replacement therapy in ESRD patients with cirrhosis and ascites” Annual Dialysis conference, March 7-10, 2009, Houston, TX [invited lecture]
21. “Vitamin D levels are positively correlated with Hemoglobin levels in diabetic patients with chronic kidney disease.” Annual meeting of the American Society of nephrology.  November 4-8, 2009, San Diego, CA. [poster]*
     *This finding was reported in Renal and Urology news
22. “Calciphylaxis: incidence in peritoneal dialysis” Annual Dialysis Conference, March 6-9, 2010 Seattle, WA.[Invited lecture]
23. “Chronic Kidney disease negatively impacts survival in patients undergoing carotid-endarterectomy surgery”. ASN annual meeting , Nov 18-21 2010, Denver CO [ Poster]
24. “Serum intact parathormone as a cardiovascular risk factor for patients with moderate CKD”  ASN Annual meeting, Nov 18-21 2010, Denver, CO [ Poster] 
25. “Technique failure due to Peritonitis: what is the risk? How can this be prevented?” Annual Dialysis conference, February 20-22, 2011, Phoenix, AZ [Invited lecture]
26. “Glucose sparing strategies and results”. Annual Dialysis conference, February 20-22, 2011 Phoenix, AZ [Invited lecture]
27. “Treatment of 25-OH Vitamin D deficiency in Stage III/IV CKD patients with ergocalciferol reduces the cardiovascular risk” National Kidney Foundation annual meeting  April 25-28, 2011 Las Vegas, NV [Poster]*   
    *This finding was reported in Renal and Urology news
28. “Acute serum sickness in renal transplant: a case series” National Kidney Foundation annual meeting  April 25-28 2011 Las Vegas, NV [ Poster]
29. “Prevention of peritoneal fibrosis using Decorin gene therapy”  Annual DCI research meeting, October 28-30, 2011, Tampa, FL. [oral]
30. “Technique failure due to peritonitis: causes and prevention strategies” Annual Dialysis Conference, February 26-28, 2012. San Antonio, TX.[invited lecture]
31. “Decorin gene therapy via hybrid nanoparticles and adeno-associated virus leads to prevention of peritoneal fibrosis in a rat model of peritonitis” Annual Dialysis Conference, February 26-28, 2012, San Antonio, TX. [poster,]
32. “Nanotechnology based gene therapy for prevention of peritoneal fibrosis”  Annual Dialysis Conference , March 9-12, 2013, Seattle, WA [oral]
33. “Technique failure due to peritonitis: causes and prevention strategies” Annual Dialysis Conference, March 9-12, 2013.Seattle, WA [invited lecture]
34. CKD and aging: what does soy have to do with it? MU Institute for Clinical and Translational Science Seminar. April 2013 [clinical presenter]
35. Preventing PD drop outs; Clinical, patient and System factors. Annual Dialysis conference, February 8-11, 2014, Atlanta , GA
36. Peritonitis as a cause of technique failure: prevention strategies.  Annual Dialysis Conference, Atlanta, GA February 8-11, 2014.
37.  Calciphylaxis/Calcific Uremic Arteriolopathy in Chronic Renal Failure. Central Missouri ANNA Chapter, Columbia, MO March 13, 2014
38. Cardiac Disease in Dialysis patients. Grand Rounds, Department of Medicine, University of Missouri-columbia, MO. May 14, 2014